 | • レポートコード：QYR9ST04994 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、ペプチド及びヘパリンの世界市場について調査・分析し、ペプチド及びヘパリンの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（静脈内、経口経路、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のペプチド及びヘパリン市場動向 ・主要企業別マーケットシェア ・ペプチド及びヘパリンの種類別市場規模2014-2019 （静脈内、経口経路、その他） ・ペプチド及びヘパリンの用途別市場規模2014-2019 （病院薬局、小売薬局、オンライン薬局） ・ペプチド及びヘパリンの北米市場：主要企業・種類別/用途別市場規模 ・ペプチド及びヘパリンのヨーロッパ市場：主要企業・種類別/用途別市場規模 ・ペプチド及びヘパリンの中国市場：主要企業・種類別/用途別市場規模 ・ペプチド及びヘパリンの日本国内市場：主要企業・種類別/用途別市場規模 ・ペプチド及びヘパリンの東南アジア市場：主要企業・種類別/用途別市場規模 ・ペプチド及びヘパリンのインド市場：主要企業・種類別/用途別市場規模 ・ペプチド及びヘパリンの中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Eli Lilly、Novo Nordisk、Sanofi、Pfizer、Abbott Laboratories、Takeda、Teva、Leo Pharma、Aspen、Bachem、Hemmo Pharma、Sun Pharmaceutical、Wockhardt、AmbioPharm） ・ペプチド及びヘパリンの市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Peptides are amino acids’ short chains connected through peptide bonds. Peptides are molecules that are commonly known as proteins, whose functions are determined on the basis of the amino acid sequence and size. Heparin is known as disaccharide anticoagulant, commonly referred to as blood thinner, which prevents formation of blood clots. Mast cells and basophils in a body produce heparin, which is stored in mast cells and secreted wherever injuries occur.In 2018, the global Peptide and Heparin market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Peptide and Heparin status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Peptide and Heparin development in United States, Europe and China.
The key players covered in this study
Eli Lilly
Novo Nordisk
Sanofi
Pfizer
Abbott Laboratories
Takeda
Teva
Leo Pharma
Aspen
Bachem
Hemmo Pharma
Sun Pharmaceutical
Wockhardt
AmbioPharm
Market segment by Type, the product can be split into
Intravenous
Oral Route
Others
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Peptide and Heparin status, future forecast, growth opportunity, key market and key players.
To present the Peptide and Heparin development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Peptide and Heparin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Peptide and Heparin Market Size Growth Rate by Type (2014-2025)
1.4.2 Intravenous
1.4.3 Oral Route
1.4.4 Others
1.5 Market by Application
1.5.1 Global Peptide and Heparin Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Peptide and Heparin Market Size
2.2 Peptide and Heparin Growth Trends by Regions
2.2.1 Peptide and Heparin Market Size by Regions (2014-2025)
2.2.2 Peptide and Heparin Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Peptide and Heparin Market Size by Manufacturers
3.1.1 Global Peptide and Heparin Revenue by Manufacturers (2014-2019)
3.1.2 Global Peptide and Heparin Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Peptide and Heparin Market Concentration Ratio (CR5 and HHI)
3.2 Peptide and Heparin Key Players Head office and Area Served
3.3 Key Players Peptide and Heparin Product/Solution/Service
3.4 Date of Enter into Peptide and Heparin Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Peptide and Heparin Market Size by Type (2014-2019)
4.2 Global Peptide and Heparin Market Size by Application (2014-2019)
5 United States
5.1 United States Peptide and Heparin Market Size (2014-2019)
5.2 Peptide and Heparin Key Players in United States
5.3 United States Peptide and Heparin Market Size by Type
5.4 United States Peptide and Heparin Market Size by Application
6 Europe
6.1 Europe Peptide and Heparin Market Size (2014-2019)
6.2 Peptide and Heparin Key Players in Europe
6.3 Europe Peptide and Heparin Market Size by Type
6.4 Europe Peptide and Heparin Market Size by Application
7 China
7.1 China Peptide and Heparin Market Size (2014-2019)
7.2 Peptide and Heparin Key Players in China
7.3 China Peptide and Heparin Market Size by Type
7.4 China Peptide and Heparin Market Size by Application
8 Japan
8.1 Japan Peptide and Heparin Market Size (2014-2019)
8.2 Peptide and Heparin Key Players in Japan
8.3 Japan Peptide and Heparin Market Size by Type
8.4 Japan Peptide and Heparin Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Peptide and Heparin Market Size (2014-2019)
9.2 Peptide and Heparin Key Players in Southeast Asia
9.3 Southeast Asia Peptide and Heparin Market Size by Type
9.4 Southeast Asia Peptide and Heparin Market Size by Application
10 India
10.1 India Peptide and Heparin Market Size (2014-2019)
10.2 Peptide and Heparin Key Players in India
10.3 India Peptide and Heparin Market Size by Type
10.4 India Peptide and Heparin Market Size by Application
11 Central & South America
11.1 Central & South America Peptide and Heparin Market Size (2014-2019)
11.2 Peptide and Heparin Key Players in Central & South America
11.3 Central & South America Peptide and Heparin Market Size by Type
11.4 Central & South America Peptide and Heparin Market Size by Application
12 International Players Profiles
12.1 Eli Lilly
12.1.1 Eli Lilly Company Details
12.1.2 Company Description and Business Overview
12.1.3 Peptide and Heparin Introduction
12.1.4 Eli Lilly Revenue in Peptide and Heparin Business (2014-2019)
12.1.5 Eli Lilly Recent Development
12.2 Novo Nordisk
12.2.1 Novo Nordisk Company Details
12.2.2 Company Description and Business Overview
12.2.3 Peptide and Heparin Introduction
12.2.4 Novo Nordisk Revenue in Peptide and Heparin Business (2014-2019)
12.2.5 Novo Nordisk Recent Development
12.3 Sanofi
12.3.1 Sanofi Company Details
12.3.2 Company Description and Business Overview
12.3.3 Peptide and Heparin Introduction
12.3.4 Sanofi Revenue in Peptide and Heparin Business (2014-2019)
12.3.5 Sanofi Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Peptide and Heparin Introduction
12.4.4 Pfizer Revenue in Peptide and Heparin Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Abbott Laboratories
12.5.1 Abbott Laboratories Company Details
12.5.2 Company Description and Business Overview
12.5.3 Peptide and Heparin Introduction
12.5.4 Abbott Laboratories Revenue in Peptide and Heparin Business (2014-2019)
12.5.5 Abbott Laboratories Recent Development
12.6 Takeda
12.6.1 Takeda Company Details
12.6.2 Company Description and Business Overview
12.6.3 Peptide and Heparin Introduction
12.6.4 Takeda Revenue in Peptide and Heparin Business (2014-2019)
12.6.5 Takeda Recent Development
12.7 Teva
12.7.1 Teva Company Details
12.7.2 Company Description and Business Overview
12.7.3 Peptide and Heparin Introduction
12.7.4 Teva Revenue in Peptide and Heparin Business (2014-2019)
12.7.5 Teva Recent Development
12.8 Leo Pharma
12.8.1 Leo Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Peptide and Heparin Introduction
12.8.4 Leo Pharma Revenue in Peptide and Heparin Business (2014-2019)
12.8.5 Leo Pharma Recent Development
12.9 Aspen
12.9.1 Aspen Company Details
12.9.2 Company Description and Business Overview
12.9.3 Peptide and Heparin Introduction
12.9.4 Aspen Revenue in Peptide and Heparin Business (2014-2019)
12.9.5 Aspen Recent Development
12.10 Bachem
12.10.1 Bachem Company Details
12.10.2 Company Description and Business Overview
12.10.3 Peptide and Heparin Introduction
12.10.4 Bachem Revenue in Peptide and Heparin Business (2014-2019)
12.10.5 Bachem Recent Development
12.11 Hemmo Pharma
12.12 Sun Pharmaceutical
12.13 Wockhardt
12.14 AmbioPharm
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Peptide and Heparin Key Market Segments
Table Key Players Peptide and Heparin Covered
Table Global Peptide and Heparin Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Peptide and Heparin Market Size Market Share by Type 2014-2025
Figure Intravenous Figures
Table Key Players of Intravenous
Figure Oral Route Figures
Table Key Players of Oral Route
Figure Others Figures
Table Key Players of Others
Table Global Peptide and Heparin Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Peptide and Heparin Report Years Considered
Table Global Peptide and Heparin Market Size 2014-2025 (Million US$)
Figure Global Peptide and Heparin Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Peptide and Heparin Market Size by Regions 2014-2025 (Million US$)
Table Global Peptide and Heparin Market Size by Regions 2014-2019 (Million US$)
Table Global Peptide and Heparin Market Share by Regions 2014-2019
Figure Global Peptide and Heparin Market Share by Regions 2014-2019
Figure Global Peptide and Heparin Market Share by Regions 2019
Table Market Top Trends
Table Global Peptide and Heparin Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Peptide and Heparin Market Share by Manufacturers (2014-2019)
Figure Global Peptide and Heparin Market Share by Manufacturers in 2018
Table Global Peptide and Heparin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Peptide and Heparin Product/Solution/Service
Table Date of Enter into Peptide and Heparin Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Peptide and Heparin Market Size by Type (2014-2019) (Million US$)
Table Global Peptide and Heparin Market Size Share by Type (2014-2019)
Figure Global Peptide and Heparin Market Size Market Share by Type (2014-2019)
Table Global Peptide and Heparin Market Size by Application (2014-2019) (Million US$)
Table Global Peptide and Heparin Market Size Share by Application (2014-2019)
Figure Global Peptide and Heparin Market Size Market Share by Application (2014-2019)
Figure Global Peptide and Heparin Revenue Market Share by Application in 2018
Figure United States Peptide and Heparin Market Size 2014-2019 (Million US$)
Table United States Key Players Peptide and Heparin Revenue (2018-2019) (Million US$)
Table United States Key Players Peptide and Heparin Market Share (2018-2019)
Table United States Peptide and Heparin Market Size by Type (2014-2019) (Million US$)
Table United States Peptide and Heparin Market Share by Type (2014-2019)
Table United States Peptide and Heparin Market Size by Application (2014-2019) (Million US$)
Table United States Peptide and Heparin Market Share by Application (2014-2019)
Figure Europe Peptide and Heparin Market Size 2014-2019 (Million US$)
Table Europe Key Players Peptide and Heparin Revenue (2018-2019) (Million US$)
Table Europe Key Players Peptide and Heparin Market Share (2018-2019)
Table Europe Peptide and Heparin Market Size by Type (2014-2019) (Million US$)
Table Europe Peptide and Heparin Market Share by Type (2014-2019)
Table Europe Peptide and Heparin Market Size by Application (2014-2019) (Million US$)
Table Europe Peptide and Heparin Market Share by Application (2014-2019)
Figure China Peptide and Heparin Market Size 2014-2019 (Million US$)
Table China Key Players Peptide and Heparin Revenue (2018-2019) (Million US$)
Table China Key Players Peptide and Heparin Market Share (2018-2019)
Table China Peptide and Heparin Market Size by Type (2014-20189) (Million US$)
Table China Peptide and Heparin Market Share by Type (2014-2019)
Table China Peptide and Heparin Market Size by Application (2014-2019) (Million US$)
Table China Peptide and Heparin Market Share by Application (2014-2019)
Figure Japan Peptide and Heparin Market Size 2014-2019 (Million US$)
Table Japan Key Players Peptide and Heparin Revenue (2018-2019) (Million US$)
Table Japan Key Players Peptide and Heparin Market Share (2018-2019)
Table Japan Peptide and Heparin Market Size by Type (2014-2019) (Million US$)
Table Japan Peptide and Heparin Market Share by Type (2014-2019)
Table Japan Peptide and Heparin Market Size by Application (2014-2019) (Million US$)
Table Japan Peptide and Heparin Market Share by Application (2014-2019)
Figure Southeast Asia Peptide and Heparin Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Peptide and Heparin Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Peptide and Heparin Market Share (2018-2019)
Table Southeast Asia Peptide and Heparin Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Peptide and Heparin Market Share by Type (2014-2019)
Table Southeast Asia Peptide and Heparin Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Peptide and Heparin Market Share by Application (2014-2019)
Figure India Peptide and Heparin Market Size 2014-2019 (Million US$)
Table India Key Players Peptide and Heparin Revenue (2018-2019) (Million US$)
Table India Key Players Peptide and Heparin Market Share (2018-2019)
Table India Peptide and Heparin Market Size by Type (2014-2019) (Million US$)
Table India Peptide and Heparin Market Share by Type (2014-2019)
Table India Peptide and Heparin Market Size by Application (2014-2019) (Million US$)
Table India Peptide and Heparin Market Share by Application (2014-2019)
Figure Central & South America Peptide and Heparin Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Peptide and Heparin Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Peptide and Heparin Market Share (2018-2019)
Table Central & South America Peptide and Heparin Market Size by Type (2014-2019) (Million US$)
Table Central & South America Peptide and Heparin Market Share by Type (2014-2019)
Table Central & South America Peptide and Heparin Market Size by Application (2014-2019) (Million US$)
Table Central & South America Peptide and Heparin Market Share by Application (2014-2019)
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Peptide and Heparin Business (2014-2019) (Million US$)
Figure Eli Lilly Revenue Growth Rate in Peptide and Heparin Business (2014-2019)
Table Eli Lilly Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Peptide and Heparin Business (2014-2019)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Peptide and Heparin Business (2014-2019)
Table Novo Nordisk Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Peptide and Heparin Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Peptide and Heparin Business (2014-2019)
Table Sanofi Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Peptide and Heparin Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Peptide and Heparin Business (2014-2019)
Table Pfizer Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Peptide and Heparin Business (2014-2019)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Peptide and Heparin Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Takeda Company Details
Table Takeda Revenue in Peptide and Heparin Business (2014-2019)(Million US$)
Figure Takeda Revenue Growth Rate in Peptide and Heparin Business (2014-2019)
Table Takeda Recent Development
Table Teva Company Details
Table Teva Revenue in Peptide and Heparin Business (2014-2019)(Million US$)
Figure Teva Revenue Growth Rate in Peptide and Heparin Business (2014-2019)
Table Teva Recent Development
Table Leo Pharma Company Details
Table Leo Pharma Revenue in Peptide and Heparin Business (2014-2019)(Million US$)
Figure Leo Pharma Revenue Growth Rate in Peptide and Heparin Business (2014-2019)
Table Leo Pharma Recent Development
Table Aspen Company Details
Table Aspen Revenue in Peptide and Heparin Business (2014-2019)(Million US$)
Figure Aspen Revenue Growth Rate in Peptide and Heparin Business (2014-2019)
Table Aspen Recent Development
Table Bachem Company Details
Table Bachem Revenue in Peptide and Heparin Business (2014-2019)(Million US$)
Figure Bachem Revenue Growth Rate in Peptide and Heparin Business (2014-2019)
Table Bachem Recent Development
Table Hemmo Pharma Company Details
Table Sun Pharmaceutical Company Details
Table Wockhardt Company Details
Table AmbioPharm Company Details
Table Global Peptide and Heparin Market Size by Regions (Million US$) 2019-2025
Figure Global Peptide and Heparin Market Size Share by Regions (2019-2025)
Figure Global Peptide and Heparin Market Size Share by Regions in 2025
Figure United States Peptide and Heparin Market Size Forecast (2019-2025)(Million USD)
Figure Europe Peptide and Heparin Market Size Forecast (2019-2025)(Million USD)
Figure China Peptide and Heparin Market Size Forecast (2019-2025)(Million USD)
Figure Japan Peptide and Heparin Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Peptide and Heparin Market Size Forecast (2019-2025)(Million USD)
Figure India Peptide and Heparin Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Peptide and Heparin Market Size Forecast (2019-2025)(Million USD)
Table Global Peptide and Heparin Market Size by Product (2019-2025) (Million US$)
Figure Global Peptide and Heparin Market Size by Product (2019-2025)
Figure Global Peptide and Heparin Market Size by Product in 2025
Table Global Peptide and Heparin Market Size by Application (2019-2025) (Million US$)
Figure Global Peptide and Heparin Market Size by Application (2019-2025)
Figure Global Peptide and Heparin Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
ペプチドベース感染治療薬の世界市場：市場規模・現状・予測 Peptide therapeutics are stable, safe, tolerable, possess selective nature, and effective.Hospital pharmacies segment enjoys the highest market share by revenue thereby dominating the global market. In 2018, the global Peptide Based Infection Therapeutics market size was xx million US$ and it is exp…- ペプチドベース心血管治療薬の世界市場：市場規模・現状・予測 Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, heart failure, hypertensive heart diseas…
- グリコシル化ヘモグロビン及びCペプチドの世界市場：インサイト・予測 Glycosylated hemoglobin refers to a hemoglobin molecule to which glucose is bound. C-peptide is a short connecting peptide that connects two chains of the insulin molecule.This market is driven by several factors such as increasing incidences of cancers, diabetes, and other blood disorders, changing…
- 世界の銅ペプチド市場：専門的調査 Copper peptide (GHK-Cu) is a compound formed by the complexation of copper ions and tripeptide-1. The copper ions in it can promote the repair. Tripeptide-1 (GHK) acts as a signal peptide to promote skin matrix synthesis. Copper peptide can treat allergies, repair red blood, acne and anti-inflammato…
- 世界の銅ペプチド市場：専門的調査 Copper peptide (GHK-Cu) is a compound formed by the complexation of copper ions and tripeptide-1. The copper ions in it can promote the repair. Tripeptide-1 (GHK) acts as a signal peptide to promote skin matrix synthesis. Copper peptide can treat allergies, repair red blood, acne and anti-inflammato…